Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

Since then, though, Moderna has traveled along a rough path. Demand for the coronavirus vaccine has dropped significantly, and even the company's second approved product -- respiratory syncytial ...

The Nintendo Switch 2 is finally official, and with the announcement comes a first look at the system. As well as new Joy-Cons (which appear to also function as a mouse, thanks to optical sensors ...

Moderna is down 80% from its 52-week high as ... and try to beat 2025 revenue guidance. The second regulatory catalyst is a potential expanded label for mRESVIA in high-risk adults 18-59 years ...

Ratings for Moderna MRNA were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings ...

A bad seven-month stretch just got worse for Moderna (NASDAQ ... Don’t miss this second chance at a potentially lucrative opportunity Ever feel like you missed the boat in buying the most ...

Simply sign up to the German economy myFT Digest -- delivered directly to your inbox. Germany’s economy shrank for a second straight year in 2024, underlining the severity of the downturn facing ...

Management expects to generate the majority of this figure in the second half of the year. Shares of Moderna were down nearly 17% on Monday, likely due to the guidance cut. This revised guidance ...

Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. The stock broke down from a two ...